GlassScriptPhysician profile
Shannon N Steiner
NPI 1942740071
$6,946.64
in general payments reported to CMS, 2019-2025
35 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,850 · 2022: $1,666 · 2023: $2,330 · 2024: $941 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,271 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,271.34 |
| Education | $159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,212.70 | 2021-2024 | Airsupra, Fasenra, Tezspire |
| Genzyme Corporation | $877.36 | 2021-2025 | |
| Glaxosmithkline, LLC. | $860.42 | 2021-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Actelion Pharmaceuticals US, INC. | $799.30 | 2021-2023 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $363.35 | 2021-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| United Therapeutics Corporation | $345.82 | 2021-2024 | Tyvaso |
| Grifols USA, LLC | $312.82 | 2021-2023 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $290.83 | 2021-2024 | Wakix |
| Electromed, INC. | $187.48 | 2022-2024 | Smartvest |
| Mylan Specialty L.P. | $183.33 | 2021-2024 | Yupelri |
| Inspire Medical Systems, INC. | $162.12 | 2023 | Inspire |
| Novartis Pharmaceuticals Corporation | $160.28 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $158.24 | 2022-2024 | Dupixent |
| Genentech USA, INC. | $108.17 | 2022-2024 | Xolair |
| Jazz Pharmaceuticals INC. | $105.90 | 2023-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $94.34 | 2022 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2023 | |
| Merck Sharp & Dohme LLC | $67.70 | 2022-2024 | Zerbaxa, Recarbrio |
| Inogen, INC. | $57.58 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pulmonx Corporation | $53.02 | 2024-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Avadel Cns Pharmaceuticals, LLC | $52.56 | 2024 | Lumryz |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.52 | 2021-2023 | Xifaxan, Trulance |
| Insmed, INC. | $48.62 | 2021-2024 | Arikayce |
| Vapotherm INC | $44.11 | 2021 | |
| Covis Pharma Gmbh | $36.80 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.37 | 2021-2023 | Glassia |
| Lucid Diagnostics INC. | $29.86 | 2022 | |
| Advanced Respiratory, INC | $29.54 | 2021 | |
| Pfizer INC. | $29.00 | 2022-2023 | |
| Vifor Pharma, INC. | $27.60 | 2024 | Zemaira |
| Philips North America LLC | $21.26 | 2023 | |
| Phadia US INC. | $18.17 | 2023 | Immunocap |
| Teva Pharmaceuticals USA, INC. | $16.03 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.50 | 2021 | |
| Tactile Systems Technology INC | $12.95 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Steiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.